Echo Therapeutics, Inc. Stock Price - ECTE

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Echo Therapeutics, Inc. ECTE Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.002 0.00 0.00 0.00 0.002 16:00:01
Bid Price Ask Price Spread Spread % News
0.001 0.0035 0.0025 71.43% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 30 34,611 0.0005 - 0.013
Last Trade Time Type Quantity Stock Price Currency
11:53:32 30 $ 0.0035 USD

Echo Therapeutics, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 26.59k 13.3M $ -22.2M - -0.00 10.88M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Echo Therapeutics, Inc. News

Latest ECTE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ECTE Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.00150.0020.00120.001781011k7k0.000533.33%
1 Month0.00450.0060.00120.0026810312k53k-0.0025-55.56%
3 Months0.00070.00690.00060.0031100312k49k0.0013185.71%
6 Months0.00070.0130.00050.0034100312k37k0.0013185.71%
1 Year0.0070.0130.00050.00403506k28k-0.005-71.43%
3 Years1.451.450.00050.13162564k30k-1.448-99.86%
5 Years1.451.450.00050.13162564k30k-1.448-99.86%

Echo Therapeutics, Inc. Description

We are a medical device company with expertise in advanced skin permeation technology. We are developing a non-invasive. wireless continuous glucose monitoring (CGM) system for initial use in the diabetes outpatient market. We believe other significant opportunities exist in the wearable-health consumer market and the hospital setting. The transdermal skin preparation component of our CGM System allows for enhanced skin permeation that will enable extraction of analytes such as glucose, enhanced delivery of topical pharmaceuticals and other applications.


Your Recent History
USOTC
ECTE
Echo Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.